Clinical Study Results
Research Sponsor: AstraZeneca K.K.
Drugs Studied: MEDI9447 (oleclumab)
Study Title: A study to learn about the safety of MEDI9447 in Japanese men and women who have advanced cancers
Thank you!
Thank you to the participants who took part in the clinical study for the study drug MEDI9447, also called oleclumab, and to the families of the participants.
AstraZeneca K.K. sponsored this study and thinks it is important to share the results. An independent non-profit organization called CISCRP helped prepare this summary of the study results.
If you or a family member participated in the study and have questions about the results, please speak with the study doctor or staff at your study site.